Louis Edward Tamayo serves as Executive at Lexeo Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Louis Edward Tamayo has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 29, 2025 involved receiving (via award) 45,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Aug 29, 2025 | LXEO | $0 | Award | 45,000 | $N/A | Discretionary |
Louis Edward Tamayo currently holds 45,000 shares of Lexeo Therapeutics, Inc. (LXEO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Louis Edward Tamayo has been a net neutral trader of LXEO stock. They have purchased $0 and sold $0 worth of shares.
Louis Edward Tamayo's most recent insider trade was on Aug 29, 2025, when they sold 45,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted